m+Medelevator.RU
← Поиск публикаций
Annals of vascular surgery · 2025

Prognostic Value of the HCO3-to-Lactate Ratio in Acute Mesenteric Ischemia: A Retrospective Analysis.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Pinelo Andreia, Loureiro Luís, Pires Marco, Mendes Daniel, Almeida Henrique, Queirós Miguel, Cabral João, Cardoso Samuel, Machado Rui

Аннотация

BACKGROUND: Acute mesenteric ischemia (AMI) is a life-threatening emergency with persistently high mortality rates, requiring improved tools for perioperative risk assessment. This study investigates the real-world outcomes of patients with occlusive arterial AMI undergoing surgery, focusing on predictors of short-term mortality.

METHODS: A retrospective, single-center analysis was conducted on patients undergoing emergent mesenteric surgery for occlusive arterial AMI between January 2015 and May 2024. The primary outcome was 30-day survival; secondary outcomes included predictors of in-hospital mortality based on preoperative laboratory parameters.

RESULTS: Sixty patients (mean age 75 ± 12 years) were included, with a 30-day survival rate of 45%. Of the 60 patients, 15 (75%) with acute-on-chronic symptoms (n = 20) survived, compared to 12 (30%) with acute onset (n = 40) (P = 0.003). Multivariate Cox regression identified lactate, bicarbonate (HCO3), the HCO3-to-lactate ratio, and neutrophil count as predictors of 30-day mortality. The HCO3-to-lactate ratio ≤10 demonstrated high predictive accuracy (area under the curve 0.832, sensitivity 90.6%, specificity 75%). In acute-onset cases, excluding acute-on-chronic symptoms improved specificity to 100%.

CONCLUSION: The HCO3-to-lactate ratio is a robust prognostic marker in occlusive arterial AMI, reflecting both tissue hypoperfusion and impaired metabolic compensation. These findings support its potential utility in risk stratification and in guiding clinical decision-making in the emergent management of AMI.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты